Transcription profiling of human VHL treated A498 renal cancer cells

ABSTRACT: A498 cells, established from a clear cell renal cell cancer of a 52 years old male patient, were obtained from ATCC and maintained in DMEM supplemented with 10% fetal calf serum (FCS). This cell line does not express functional VHL. A498 subclones stably transfected with HA-pVHL30 or control plasmid have been described and were maintained in 0.5 mg/ml G418.

ORGANISM(S): Homo sapiens

SUBMITTER: Edward Oakeley 

PROVIDER: E-MEXP-13 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress